Value-based cost sharing in the United States and elsewhere can increase patients' use of high-value goods and services

Health Affairs

Volumn 32, Issue 4, 2013, Pages 704-712

  Thomson, Sarah ^a   Schang, Laura ^a   Chernew, Michael E ^b  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

ARTICLE; DRUG COST; DRUG EFFICACY; DRUG INDICATION; ECONOMIC EVALUATION; EXERCISE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH DISPARITY; HEALTH SERVICE; HUMAN; INTERNATIONAL COOPERATION; OUTPATIENT CARE; PREVENTIVE MEDICINE; SMOKING CESSATION; UNITED STATES;

COST SHARING; DRUG COSTS; HUMANS; INSURANCE, HEALTH; POLICY MAKING; PREFERRED PROVIDER ORGANIZATIONS; PREVENTIVE MEDICINE; PROGRAM EVALUATION; QUALITY OF HEALTH CARE; UNITED STATES; VALUE-BASED PURCHASING;

EID: 84877966029     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2012.0964     Document Type: Article

References (37)

1. Fendrick AM. Value-based insurance design landscape digest [Internet]. Ann Arbor (MI): University of Michigan; 2009 [cited 2013 Mar 6]. Available from: http://www.sph.umich.edu/vbidcenter/registry/pdfs/NPC_VBIDreport_7-22-09.pdf
2. Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N, et al. Adverse effects associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285(4):421-9.
3. Hsu J, Price M, Huang J, Brand R, Fung V, Hui R, et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006;354(22):2349-59.
4. Goldman D, Joyce G, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298(1): 61-9.
5. Chernew M, Juster I, Shah M, Wegh A, Rosenberg S, Rosen A. Evidence that value-42based insurance can be effective. Health Aff (Millwood). 2010;29(3):530-6.
6. Choudhry N, Avorn J, Glynn R, Antman E, Schneeweiss S, Toscano M, et al. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011; 365(22):2088-97.
7. Lohr KN, Brook RH, Kamberg CJ, Goldberg GA, Leibowitz A, Keesey J, et al. Effect of cost sharing on use of medically effective and less effective care. Med Care. 1986;24(9 Suppl): S31-8.
8. Mutual Information System on Social Protection. Comparative tables on social protection: situation on 1 January 2011 [Internet]. Brussels: European Union; [cited 2013 Mar 6]. Available for download from: http://www.missoc.org/MISSOC/comparativeTables
9. European Observatory on Health Systems and Policies. Health Systems in Transition (HiT) series [home page on the Internet]. Brussels: European Observatory; c2013 [cited 2013 Mar 6]. Available from: http://www.euro.who.int/en/who-53we-are/partners/observatory/health-systems-in-transition-hitseries
10. Bertelsman Stiftung. Health Policy Monitor [home page on the Internet]. Cologne: Bertelsman Stiftung; 2011 [cited 2011 Oct 21]. Available from: http://hpm.org/
11. Pharmaceutical Health Information System [home page on the Internet]. Vienna: PHIS; 2011 [cited 2013 Mar 6]. Available from: http://phis.goeg.at
12. We examined policies in Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, the Netherlands, Norway, Portugal, Spain, Switzerland, the United Kingdom, and the United States. To access the Appendix, click on the Appendix link in the box to the right of the article online.
13. Federal Office of Public Health. Statistik der obligatorischen Krankenversicherung 2011 [Internet]. Bern: Swiss Confederation; 2011 [cited 2013 Mar 15]. Table 11.07d: Verteilung der Versicherten (Kinder und Erwachsene) nach Versicherungsform ab 2001. German. Available for download from: http://www.bag.admin.ch/themen/krankenversicherung/01156/index.html?lang=de
14. Scanlon DP, Lindrooth RC, Christianson JB. Steering patients to safer hospitals? The effect of a tiered hospital network on hospital admissions. Health Serv Res. 2008; 43(5 pt 2):1849-68.
15. Boonen LHHM, Schut FT, Koolman X. Consumer channelling by health insurers: natural experiments with preferred providers in the Dutch pharmacy market. Health Econ. 2008;17(3):299-316.
16. There was a mandatory annual deductible of €220 (US$298.46) in 2012 for all non-primary care health services for adults (those younger than eighteen are exempt). Patients can choose to pay a higher deductible, up to a maximum of €500 (US $678.32) per year, in return for lower premiums.
17. KiesBeter. Waiver for statutory deductible-overview, insurers. Bilthoven: KiesBeter; 2011. Dutch.
18. Van der Maat MJP, de Jong JD. Deductibles in health insurance: the perspective of insurees. A study based on the health care consumer panel. Utrecht: NIVEL; 2010. Dutch.
19. Sorenson C, Drummond M, Kanavos P. Ensuring value for money in health care: the role of health technology assessment in the European Union. Copenhagen: World Health Organization; 2008.
20. Chevreul K, Durand-18Zaleski I, Bahrami S, Hernández-Quevedo C, Mladovsky P. France: health system review. Health Syst Transit. 2010; 12(6):1-291.
21. Teperi J, Porter ME, Vuorenkoski L, Baron JF. The Finnish health care system: a value-based perspective. Helsinki: SITRA; 2009.
22. Chernew M, Rosen AB, Fendrick AM. Value-based insurance design. Health Aff (Millwood). 2007;26(2): w195-203. DOI: 10.1377/hlthaff.26.2.w195.
23. Kanavos P, Reinhardt UE. Reference pricing for drugs: is it compatible with US health care? Health Aff (Millwood). 2003;22(3):16-30.
24. Aaserud M, Austvoll-Dahlgren A, Kösters J, Oxman A, Ramsay C, Sturm H. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies. Cochrane Database Syst Rev. 2006; (2):CD005979.
25. Morgan S, Hanley G, Greyson D. Comparison of tiered formularies and reference pricing policies: a systematic review. Open Medicine [serial on the Internet]. 2009;3(3). [cited 2013 Mar 18]. Available from: http://www.openmedicine.ca/article/view/270/254
26. Thomson S, Osborn R, Squires D, Jun M. International profiles of health care systems. New York (NY): Commonwealth Fund; 2012.
27. Jochelson K. Paying the patient. improving health using financial incentives. London: King's Fund; 2007.
28. Schmidt H, Stock S, Gerber A.What can we learn from German health incentive schemes? Br Med J. 2009;339:3504.
29. Stock S, Schmidt H, Büscher G, Gerber A, Drabik A, Graf C, et al. Financial incentives in the German Statutory Health Insurance: new findings, new questions. Health Policy. 2010;96(1):51-6.
30. Stock S, Stollenwerk B, Klever-5 Deichert G, Redaelli M, Büscher G, Graf C. Preliminary analysis of short term financial implications of a prevention bonus program: first results from the German Statutory Health Insurance. Int J Public Health. 2008;53(2):78-86.
31. Bödeker W, Friedel H, Friedrichs M. Economic benefit of BKK bonus programs. Die BKK. 2008;4:214-8. German.
32. Dreier M, Linger H. Bonus for healthy behavior-first results of a statutory sickness fund from 2004. Gesundheitswesen. 2006;7:68. German.
33. Harrison K, Anderson G. Employee wellness incentives [Internet]. Cologne: Health Policy Monitor; 2010 [cited 2013 Mar 6]. Available from: http://www.hpm.org/en/Surveys/Johns_Hopkins_Bloomberg_School_of__Publ._H_-21_USA/15/Employee_Wellness_Incentives.html
34. Baicker K, Cutler D, Song Z. Workplace wellness programs can generate savings. Health Aff (Millwood). 2010;29(2):304-11.
35. Boyle S. United Kingdom (England): health system review. Health Syst Transit. 2011;13(1):1-483.
36. Corlette S, Downs D, Monahan CH, Yondorf B. State insurance exchanges face challenges in offering standardized choices alongside innovative value-3based insurance. Health Aff (Millwood). 2013;32(2): 418-26.
37. Schmidt H, Stock S, Doran T. Moving forward with wellness incentives under the Affordable Care Act: lessons from Germany. New York (NY): Commonwealth Fund; 2012.